Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,009 across all filing types
Latest filing 2020-08-05 Major Shareholding Noti…
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
关于持股5%以上股东减持股份计划的预披露公告
Major Shareholding Notification Classification · 95% confidence The document is a pre-disclosure announcement regarding a shareholder holding more than 5% of the company's shares planning to reduce their holdings. It details the shareholder's name, shareholding percentage, planned reduction amount, period, method, and reasons for the reduction. The document includes risk warnings and compliance with stock exchange rules. There are no financial statements, management discussions, or report attachments. The content is focused on a shareholder's planned share reduction, which fits the category of Major Shareholding Notification (MRQ). The document length is short (1983 characters), and it is not an announcement of a report publication or certification. Therefore, the appropriate classification is MRQ with high confidence.
2020-08-05 Chinese
关于召开2020年第一次临时股东大会的提示性公告
AGM Information Classification · 95% confidence The document is a detailed announcement about the convening of the 2020 first extraordinary general meeting of shareholders for the company 成都市贝瑞和康基因技术股份有限公司. It includes information about the meeting date, voting procedures, proposals to be voted on (including board of directors and supervisory board elections), and instructions for shareholders on how to participate and vote. The content focuses on the organization and conduct of a shareholder meeting rather than the results of voting or the meeting itself. There is no indication that this document contains the actual voting results or a summary of the meeting outcomes. Therefore, it is not a Declaration of Voting Results (DVA). It is also not a Proxy Solicitation (PSI) because it does not solicit votes but rather announces the meeting and voting procedures. The document is not an Annual Report, Interim Report, or any financial report. It is also not a Board/Management Information announcement about changes but rather a meeting notice. Given these characteristics, the document fits best as an AGM Information (AGM-R) filing, which covers presentations and materials shared during or related to the Annual General Meeting or other shareholder meetings. The document length (6498 characters) and detailed content support this classification with high confidence.
2020-08-05 Chinese
关于持股5%以上股东减持计划实施期限届满暨实施结果的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the implementation period expiration and results of a shareholding reduction plan by a shareholder holding more than 5% of the company's shares. It details the shareholder's name, reduction method, period, price range, number of shares reduced, and percentage of total share capital. It also confirms compliance with relevant laws and regulations and states that the shareholder remains above 5% ownership after the reduction. This type of document is a notification about changes in major shareholding levels, specifically a reduction in shares held by a significant shareholder. It is not a financial report, earnings release, or management information, but a formal disclosure of shareholding changes. Therefore, the appropriate classification is Major Shareholding Notification (MRQ). The document length is short and focused on shareholding changes, not a report publication or regulatory filing. Confidence is high due to clear content and context.
2020-08-04 Chinese
关于回购股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase (buyback) activities. It details the number of shares repurchased, prices, compliance with regulatory rules, and future intentions. It does not contain financial statements or earnings data, nor is it a full report or presentation. The document length is short (1534 characters) and it is a specific update on share repurchase progress, which fits the category of Transaction in Own Shares (POS).
2020-08-03 Chinese
关于股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding abnormal stock price fluctuations for the company 成都市贝瑞和康基因技术股份有限公司. It details the dates of the price changes, the company's investigation and confirmation that no undisclosed material information exists, and a risk warning to investors. The document is short (1151 characters) and focuses on regulatory disclosure about stock trading activity rather than financial results or management changes. It does not contain financial statements or detailed financial data. This type of announcement fits best under Regulatory Filings (RNS), as it is a compliance disclosure related to stock price movements and information disclosure rules, not a financial report or other specific filing type.
2020-07-23 Chinese
第八届董事会第三十次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the company's board meeting, specifically the 8th Board of Directors' 30th meeting. It includes information about the election and nomination of the 9th Board of Directors, including non-independent and independent director candidates, their qualifications, and related governance matters. It also discusses the proposal for purchasing liability insurance for directors and senior management, and the scheduling of the first extraordinary shareholders' meeting in 2020. The content focuses on board and management changes and governance structure updates, with no financial statements or earnings data. Therefore, this document fits the category of Board/Management Information (MANG). The document length (5696 characters) and detailed content support this classification with high confidence.
2020-07-22 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.